Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 3.608
Filtrar
1.
Artículo en Inglés | MEDLINE | ID: mdl-39324940

RESUMEN

Carinal reconstruction remains a technically challenging procedure for thoracic surgeons due to the complexity of airway resection and management. This is typically performed in the setting of tumour resection affecting the carina and distal trachea. Airway management of patients undergoing surgical resection of tumours involving the carina is highly challenging. This is due to an open, shared airway and the need for single-lung ventilation to facilitate surgery. Common modalities used for intraoperative ventilation include cross-table ventilation, veno-venous extra-corporeal membrane oxygenation and cardiopulmonary bypass. Cardiopulmonary bypass is usually avoided due to the requirement of full heparinization, which increases the demands of a technically challenging procedure, in addition to its contraindication in oncological resections. Extra-corporeal membrane oxygenation is not readily available in most thoracic units. This leaves cross-table ventilation, which is commonly used for open thoracotomy and sternotomy cases, but has never been reported for minimally invasive procedures.  Specifically, to the best of our knowledge, cross-table ventilation has never been used for minimally invasive robotic carinal reconstruction. We present a step-by-step video tutorial in performing surgical resection of a mediastinal tumour that was found invading the carina. This was performed in a young patient who underwent carinal reconstruction using a novel technique combining cross-table ventilation and robotic-assisted surgery.


Asunto(s)
Procedimientos de Cirugía Plástica , Procedimientos Quirúrgicos Robotizados , Humanos , Procedimientos Quirúrgicos Robotizados/métodos , Procedimientos de Cirugía Plástica/métodos , Masculino , Respiración Artificial/métodos , Neoplasias del Mediastino/cirugía , Adulto , Neoplasias de la Tráquea/cirugía
2.
Cancer Rep (Hoboken) ; 7(8): e2135, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-39158196

RESUMEN

BACKGROUND: Primary tracheal carcinoma is an exceptionally rare and life-threatening disease that presents significant diagnostic and therapeutic challenges. Delayed diagnosis due to misinterpretation of airway obstruction symptoms often leads to poorer prognoses for patients. This study aimed to explore the clinical manifestations and multidisciplinary treatment approaches for primary tracheal carcinoma in Bangladesh, with a focus on recent advancements in diagnosis and treatment. METHODS: A retrospective observational study was conducted at Bangladesh Specialized Hospital Limited, involving patients aged over 30 who were diagnosed with tracheal carcinoma and underwent multidisiplinary treatment from July 2018 to June 2019. Data were collected through patient interviews and medical record reviews. Descriptive and inferential statistical analyses were performed to examine demographic characteristics, histological variations, tumor locations, clinical signs and symptoms, treatment approaches, and outcomes. RESULTS: The study illuminated varied clinical presentations and the successful application of multidisciplinary approaches among the 13 patients. Invasive squamous cell carcinoma and adenoid cystic carcinoma were the predominant histological subtypes. Symptomatology, including dyspnea, cough, and hemoptysis, highlighted the challenge of early detection. Despite the rarity and intricacies associated with primary tracheal carcinoma, the multidisciplinary strategy yielded generally positive outcomes, as evidenced by a 1-year survival rate of 92.31% and a 5-year survival rate of 76.92%. Kaplan-Meier survival curves underscored the superior efficacy of surgical interventions over non-surgical approaches. CONCLUSION: Despite some limitations, this study contributes crucial insights into the nuanced management of primary tracheal carcinoma in the Bangladeshi context. The demonstrated success of the multidisciplinary strategy, especially surgical interventions, accentuates the importance of definitive resection. The lone case of local recurrence emphasizes the necessity for vigilant follow-up.


Asunto(s)
Neoplasias de la Tráquea , Humanos , Neoplasias de la Tráquea/terapia , Neoplasias de la Tráquea/diagnóstico , Neoplasias de la Tráquea/mortalidad , Neoplasias de la Tráquea/patología , Masculino , Femenino , Estudios Retrospectivos , Persona de Mediana Edad , Bangladesh/epidemiología , Adulto , Anciano , Terapia Combinada , Tasa de Supervivencia , Carcinoma de Células Escamosas/terapia , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/mortalidad , Carcinoma Adenoide Quístico/terapia , Carcinoma Adenoide Quístico/diagnóstico , Carcinoma Adenoide Quístico/patología , Carcinoma Adenoide Quístico/mortalidad , Pronóstico
5.
J Cardiothorac Surg ; 19(1): 468, 2024 Jul 26.
Artículo en Inglés | MEDLINE | ID: mdl-39061052

RESUMEN

INTRODUCTION: It has been reported that non-intubated anesthesia can be used successfully in adult trachea reconstruction. Herein, our center reported a case of a child undergoing non-intubated trachea reconstruction for benign tracheal tumors. CASE DESCRIPTION: In January 2023, it was decided to attempt tracheal resection and reconstruction (TRR) in an 8-year-old child with an inflammatory myofibroblastic tumor under non-intubated spontaneous breathing. After anesthesia induction, the laryngeal mask airway (LMA) was inserted. Thereafter, a bilateral superficial cervical plexus block was performed with 15 mL of 0.25% ropivacaine injected into each side. The patient was induced to resume spontaneous breathing by artificially assisted ventilation with an oxygen flow of 2 to 5 L/min and FiO2=1. After tracheotomy, the oxygen flow was increased to 15 L/min to improve the local oxygen flow to maintain the pulse oxygen saturation (SpO2) above 90% under spontaneous breathing. The patient had stable spontaneous breathing after tracheal anastomosis. The anastomosis was perfect without leakage. The LMA was removed and oxygen was given by the nasal catheter under light sedation at post anesthesia care unit (PACU). CONCLUSION: Tracheal reconstruction under spontaneous breathing may be an alternative anesthesia method for upper tracheal surgery in children.


Asunto(s)
Procedimientos de Cirugía Plástica , Tráquea , Neoplasias de la Tráquea , Humanos , Niño , Neoplasias de la Tráquea/cirugía , Procedimientos de Cirugía Plástica/métodos , Tráquea/cirugía , Masculino , Máscaras Laríngeas , Traqueotomía/métodos
6.
BMC Public Health ; 24(1): 1896, 2024 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-39010019

RESUMEN

BACKGROUND: Smoking is the major risk factor for tracheal, bronchus, and lung (TBL) cancers. We investigated the feasibility of projecting TBL cancer incidence using smoking incidence rates by incorporating a range of latent periods from the main risk factor exposure to TBL cancer diagnosis. METHODS: In this ecological study, we extracted data on TBL cancer incidence rates in Iran from 1990 to 2018 from the Global Burden of Disease (GBD) database. We also collected data on Iranian cigarette smoking patterns over the past 40 years through a literature review. The weighted average smoking incidence was calculated using a fixed-effects model with Comprehensive Meta-Analysis (CMA) software. Using these data, the five-year TBL cancer incidence in Iran was projected through time series modeling with IT Service Management (ITSM) 2000 software. A second model was developed based on cigarette smoking incidence using linear regression with SPSS (version 22), incorporating different latent periods. The results of these two models were compared to determine the best latent periods. RESULTS: An increasing trend in TBL cancer incidence was observed from 2019 to 2023 (first model: 10.30 [95% CI: 9.62, 10.99] to 11.42 [95% CI: 10.85, 11.99] per 100,000 people). In the second model, the most accurate prediction was obtained with latent periods of 17 to 20 years, with the best prediction using a 17-year latent period (10.13 to 11.40 per 100,000 people) and the smallest mean difference of 0.08 (0.84%) per 100,000 people using the standard forecasting model (the ARIMA model). CONCLUSION: Projecting an increase in TBL cancer incidence rates in the future, an optimal latent period of 17 to 20 years between exposure to cigarette smoke and TBL cancer incidence has implications for macrolevel preventive health policymaking to help reduce the burden of TBL cancer in upcoming years.


Asunto(s)
Neoplasias de los Bronquios , Fumar Cigarrillos , Predicción , Neoplasias Pulmonares , Neoplasias de la Tráquea , Humanos , Irán/epidemiología , Neoplasias Pulmonares/epidemiología , Incidencia , Neoplasias de los Bronquios/epidemiología , Neoplasias de la Tráquea/epidemiología , Prevalencia , Masculino , Fumar Cigarrillos/epidemiología , Femenino , Adulto , Persona de Mediana Edad , Factores de Riesgo , Modelos Estadísticos
7.
Clin Nucl Med ; 49(9): 854-856, 2024 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-38968555

RESUMEN

ABSTRACT: Schwannoma is a benign tumor originating from Schwann cells. It commonly occurs in the head, neck, and extremities, but rarely occurs in the trachea. Tracheal schwannoma is usually asymptomatic. We reported the 18 F-FDG PET/CT findings of a 61-year-old man with bronchoscopically biopsy-proven schwannoma, which presented challenges in differentiation from certain benign tumors and low-grade malignancies in the trachea.


Asunto(s)
Fluorodesoxiglucosa F18 , Neurilemoma , Tomografía Computarizada por Tomografía de Emisión de Positrones , Tomografía Computarizada por Rayos X , Neoplasias de la Tráquea , Humanos , Neurilemoma/diagnóstico por imagen , Neurilemoma/patología , Masculino , Persona de Mediana Edad , Neoplasias de la Tráquea/diagnóstico por imagen , Neoplasias de la Tráquea/patología , Imagen Multimodal
9.
BMC Cancer ; 24(1): 686, 2024 Jun 05.
Artículo en Inglés | MEDLINE | ID: mdl-38840114

RESUMEN

OBJECTIVE: Primary tracheal tumors are very rare and their management is not definitely established. Due to its rarity, providing patient care in terms of optimal management poses a considerable challenge. The purpose of this study was to investigate treatment outcomes in patients with these rare tumors. METHODS: We carried out a retrospective analysis of 89 patients with primary tracheal tumors treated at the Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland, over sixteen years. The study assessed patient demographics, tumor characteristics and treatment. Different treatment options were compared in terms of overall survival, disease-free survival, and progression-free survival. RESULTS: A total of 89 patients were included in the study. In the group presented, 45 patients underwent primary radical treatment and 44 were qualified for palliative treatment. Surgical resection was performed in 13 patients out of radically treated patients. The 5 year OS rates in the group of patients who underwent radical treatment and in the group of patients who underwent palliative treatment were 45.9% and 2.3%, respectively. In the group of patients who underwent radical surgical treatment, the 5 year OS was 76.9% compared to 35.8% in the group of patients who underwent nonsurgical treatment. CONCLUSION: A multidisciplinary team should decide treatment options, including in-depth consideration of surgical treatment options.


Asunto(s)
Neoplasias de la Tráquea , Humanos , Masculino , Neoplasias de la Tráquea/terapia , Neoplasias de la Tráquea/mortalidad , Neoplasias de la Tráquea/patología , Estudios Retrospectivos , Femenino , Persona de Mediana Edad , Anciano , Adulto , Resultado del Tratamiento , Anciano de 80 o más Años , Cuidados Paliativos/métodos , Adulto Joven , Polonia/epidemiología , Adolescente
10.
Cancer Epidemiol ; 91: 102585, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38815483

RESUMEN

BACKGROUND: Trachea, bronchus, and lung (TBL) cancer has demonstrated a discernible feminization and a tendency towards younger onset in recent decades. Therefore, our objective is to examine the most recent patterns in the worldwide prevalence of TBL among women of reproductive age on a global, regional, and national scale. METHODS: To assess the prevalence trends of TBL in women of reproductive age, we calculated the estimated annual percentage change (EAPC), age-standardized incidence rate (ASIR), age-standardized death rate (ASDR), and disability-adjusted life years (DALYs) for 204 countries and territories from 1990 to 2019. These calculations were based on the Global Burden of Disease (GBD) 2019 database. RESULTS: From 1990 to 2019, there was a global increase in the absolute number of incidence cases, deaths, and DALYs of TBL in women of reproductive age. However, the ASIR, ASDR, and age-standardized DALY rates were decreasing over this period, with EAPC of -0.77 (95 % confidence interval [CI]: -1.03 to -0.51), -1.08 (95 % CI: -1.34 to -0.82), and -1.10 (95 % CI: -1.36 to -0.84), respectively. This trend was observed even in regions with higher Socio-Demographic Index (SDI). East Asia consistently had the highest ASIR, ASDR, and age-standardized DALY rate, but there was a decreasing trend. Conversely, Eastern Sub-Saharan Africa displayed an increasing burden pattern. When examining countries individually, Monaco, Greenland, and Palau had the highest ASIR. Moreover, in most countries, the ASIR for TBL increased with age, particularly among women aged 35-49 years. CONCLUSIONS: Despite a global decline in ASIR, ASDR, and age-standardized DALY rates for TBL in women of reproductive age over the past three decades, there is still a troubling increase observed in low- and low-middle SDI regions. It is crucial to implement effective preventive and curative measures in these regions in order to address this concerning trend.


Asunto(s)
Neoplasias de los Bronquios , Salud Global , Neoplasias Pulmonares , Neoplasias de la Tráquea , Humanos , Femenino , Neoplasias Pulmonares/epidemiología , Neoplasias Pulmonares/mortalidad , Adulto , Persona de Mediana Edad , Neoplasias de la Tráquea/epidemiología , Neoplasias de la Tráquea/mortalidad , Salud Global/estadística & datos numéricos , Incidencia , Adulto Joven , Neoplasias de los Bronquios/epidemiología , Neoplasias de los Bronquios/mortalidad , Carga Global de Enfermedades/tendencias , Prevalencia , Adolescente , Años de Vida Ajustados por Discapacidad/tendencias
11.
Eur J Surg Oncol ; 50(7): 108390, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38723412

RESUMEN

INTRODUCTION: The surgical management of patients diagnosed with papillary thyroid carcinoma (PTC) and tracheal invasion has been a subject of ongoing discussion, particularly regarding the approach to tracheal functional reconstruction. The objective of this study was to examine the surgical technique and prognosis of PTC patients with tracheal invasion. MATERIALS AND METHODS: This study employed both univariate and multivariate Cox proportional hazard models to determine predictive factors that affect the progression-free survival (PFS) of PTC patients with tracheal invasion. Cox regression analysis was conducted by using R software version 4.3.1. RESULTS: In our study, we included 247 patients with T4a PTC. Among them, 146 patients (59.1 %) were classified as Shin I, 57 patients (23.1 %) as Shin II-III, and 44 patients (17.8 %) as Shin IV. Patients in the Shin I group underwent shaving of the tumours in the airway. The preferred surgical methods in the Shin II, III and IV groups were window resection (66.7 %), sleeve resection (34.8 %) and partial tracheal resection and skin fistula (61.8 %), respectively. Multivariate analysis demonstrated that neither tracheal surgery nor reconstruction procedures had an impact on PFS in T4a PTC patients with tracheal invasion. The 5-year DSS rate for patients receiving radioiodine (RAI) therapy was 87.3 % (p = 0.033). CONCLUSION: This study confirmed that tracheal surgery and reconstruction methods had no impact on PFS in T4a PTC patients with tracheal invasion in different Shin groups. Furthermore, RAI therapy has the potential to increase the survival rate of patients with preoperative distant metastasis of T4a PTC.


Asunto(s)
Invasividad Neoplásica , Procedimientos de Cirugía Plástica , Cáncer Papilar Tiroideo , Neoplasias de la Tiroides , Humanos , Masculino , Femenino , Cáncer Papilar Tiroideo/cirugía , Cáncer Papilar Tiroideo/patología , Persona de Mediana Edad , Neoplasias de la Tiroides/cirugía , Neoplasias de la Tiroides/patología , Adulto , Procedimientos de Cirugía Plástica/métodos , Tiroidectomía/métodos , Neoplasias de la Tráquea/cirugía , Neoplasias de la Tráquea/patología , Estudios Retrospectivos , Anciano , Tráquea/cirugía , Tráquea/patología , Modelos de Riesgos Proporcionales , Supervivencia sin Progresión , Pronóstico , Estadificación de Neoplasias
12.
In Vivo ; 38(3): 1483-1488, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38688619

RESUMEN

BACKGROUND/AIM: Tracheobronchial adenoid cystic carcinoma (ACC) is a rare type of malignancy. Although complete resection is standard treatment for localized ACC, treatment for unresectable ACC has not been established. It is unclear whether concurrent chemoradiotherapy (CCRT) followed by immune checkpoint inhibitor (ICI) therapy is effective for ACC. CASE REPORT: A 49-year-old man was admitted to our hospital for the treatment of dyspnea and thickening of the bronchial wall from the tracheal carina to the left main bronchus, as observed on a CT scan. Systemic examinations and transbronchial biopsy led to a diagnosis of locally advanced ACC. Although radiotherapy and chemotherapy are not regarded as very sensitive for ACC, a favorable response was obtained with CCRT. Following CCRT, he received ICI therapy with durvalumab for 1 year. The patient has remained in a stable condition 18 months after therapy, with no recurrence. CONCLUSION: ICI after CCRT might be a promising treatment option for unresectable tracheobronchial ACC.


Asunto(s)
Anticuerpos Monoclonales , Carcinoma Adenoide Quístico , Quimioradioterapia , Humanos , Carcinoma Adenoide Quístico/terapia , Carcinoma Adenoide Quístico/patología , Carcinoma Adenoide Quístico/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Quimioradioterapia/métodos , Anticuerpos Monoclonales/uso terapéutico , Resultado del Tratamiento , Tomografía Computarizada por Rayos X , Neoplasias de los Bronquios/terapia , Neoplasias de los Bronquios/tratamiento farmacológico , Neoplasias de los Bronquios/patología , Neoplasias de la Tráquea/terapia , Neoplasias de la Tráquea/tratamiento farmacológico , Neoplasias de la Tráquea/diagnóstico , Neoplasias de la Tráquea/patología , Biopsia
13.
Thorac Cancer ; 15(16): 1320-1324, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38634727

RESUMEN

We present a case of an adenoid cystic carcinoma (ACC) located in the upper trachea, which resulted in significant airway blockage, that was unsuitable for surgical removal due to concerns about functional impairment. Instead, endotracheal enucleation via rigid bronchoscopy was performed initially, followed by the injection of a novel tumor ablation agent known as para-toluenesulfonamide (PTS). We detail the dosing regimen, effectiveness evaluation, and post-treatment follow-up. The study highlights the potential of PTS injection as a viable alternative treatment option for patients with ACC who cannot undergo surgical resection and feasibility of lipiodol to monitor treatment effect. This research adds to the existing knowledge on ACC treatment and provides new therapeutic possibilities for patients with tracheal ACC.


Asunto(s)
Carcinoma Adenoide Quístico , Neoplasias de la Tráquea , Humanos , Carcinoma Adenoide Quístico/tratamiento farmacológico , Carcinoma Adenoide Quístico/cirugía , Carcinoma Adenoide Quístico/patología , Neoplasias de la Tráquea/tratamiento farmacológico , Neoplasias de la Tráquea/cirugía , Femenino , Compuestos de Tosilo/uso terapéutico , Compuestos de Tosilo/administración & dosificación , Persona de Mediana Edad , Sulfonamidas/uso terapéutico , Sulfonamidas/administración & dosificación , Masculino , Broncoscopía/métodos , Bencenosulfonamidas , Tolueno/análogos & derivados
14.
BMJ Case Rep ; 17(4)2024 Apr 09.
Artículo en Inglés | MEDLINE | ID: mdl-38594197

RESUMEN

Primary tracheal schwannomas are rare benign tumours. This is a case report, and therefore, no specific methods or results are applicable. We here report a case of a tracheal schwannoma in an early adolescent girl presenting with subcutaneous emphysema and symptoms of airway obstruction. Tracheal resection and reconstruction by primary anastomosis were performed. Pathology confirmed the diagnosis of tracheal schwannoma. This is an unusual life-threatening presentation of a benign rare tracheal tumour with a challenging approach to management.


Asunto(s)
Enfisema Mediastínico , Neurilemoma , Enfisema Subcutáneo , Neoplasias de la Tráquea , Femenino , Humanos , Adolescente , Enfisema Mediastínico/diagnóstico por imagen , Enfisema Mediastínico/etiología , Enfisema Mediastínico/cirugía , Tráquea/diagnóstico por imagen , Tráquea/cirugía , Tráquea/patología , Neoplasias de la Tráquea/diagnóstico , Neoplasias de la Tráquea/diagnóstico por imagen , Neurilemoma/diagnóstico , Neurilemoma/diagnóstico por imagen , Enfisema Subcutáneo/diagnóstico por imagen , Enfisema Subcutáneo/etiología
15.
Artículo en Inglés | MEDLINE | ID: mdl-38428676

RESUMEN

The aim of this study is to describe the anaesthesia management of two patients undergoing carinal resection under veno-venous extracorporeal membrane oxygenation (VV ECMO). In both cases, anaesthesia was induced and then maintained with inhalational agents during pneumonectomy and mediastinoscopy (respectively). Then the jugular and femoral veins were cannulated and VV ECMO was started after heparinization. One of the patients presented bleeding during surgery, which was treated with low-dose vasopressors (norepinephrine) and transfusion of platelets, fresh frozen plasma, and concentrated red blood cells. During VV ECMO, anaesthesia was maintained with target-controlled infusion of propofol. VV ECMO can be expected to improve surgical conditions in tracheal surgery; however, it is still a novel technique in this context. In selected patients, it would guarantee ventilatory support during carinal resection, but it is essential to carefully plan anaesthesia maintenance and prepare for VV ECMO-related complications. This technique should only be used in tertiary centres with experience in VV ECMO management.


Asunto(s)
Oxigenación por Membrana Extracorpórea , Tráquea , Humanos , Oxigenación por Membrana Extracorpórea/métodos , Masculino , Tráquea/cirugía , Persona de Mediana Edad , Femenino , Neumonectomía/métodos , Neoplasias de la Tráquea/cirugía , Anciano , Adulto , Pérdida de Sangre Quirúrgica/prevención & control
16.
Thorac Cancer ; 15(11): 878-883, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38429910

RESUMEN

BACKGROUND: Primary tracheal tumors are very rare and the literature on this subject is limited. The most common histological type of primary tracheal tumors is squamous cell carcinoma (SCC), followed by adenoid cystic carcinoma (ACC). Limited knowledge exists regarding the behavior and outcomes of different histological types of tracheal cancers. The present study aimed to address this gap by assessing the significance of the histological type of primary tracheal tumors based on our own data and to review the literature. METHODS: We carried out a retrospective analysis of 89 patients with primary tracheal tumors treated at the Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland, between 2000 and 2016. The study assessed patient demographics, tumor characteristics and treatment, with a focus on SCC, ACC, and other histological types. Different histological types were compared in terms of overall survival, disease-free survival, and progression-free survival. RESULTS: SCC was the most frequently diagnosed histological type (56.2%), followed by ACC (21.3%). Patients with SCC were typically older (78% over 60 years), predominantly male (66%), and associated with smoking. In contrast, the ACC had a more balanced gender distribution and did not correlate with smoking. ACC displayed a significantly better prognosis, with a median overall survival of 129.4 months, compared with 9.0 months for SCC. CONCLUSION: Histological type plays a crucial role in the prognosis of primary tracheal tumors. ACC demonstrated a more favorable outcome compared with SCC.


Asunto(s)
Carcinoma Adenoide Quístico , Carcinoma de Células Escamosas , Neoplasias de la Tráquea , Humanos , Masculino , Femenino , Neoplasias de la Tráquea/patología , Estudios Retrospectivos , Tráquea/patología , Pronóstico , Supervivencia sin Enfermedad , Carcinoma de Células Escamosas/patología
17.
Zentralbl Chir ; 149(3): 286-297, 2024 Jun.
Artículo en Alemán | MEDLINE | ID: mdl-38382560

RESUMEN

Malignant primary tracheal tumours are rare. The most common histological subtypes are squamous cell carcinoma and adenoid cystic carcinoma. These two entities have different prognoses and growth patterns. Tracheobronchoscopy and thoracic sectional imaging are standard diagnostic tools for tumour staging and local evaluation. Complete surgical resection of the affected tracheal segment is the treatment of choice for limited disease without distant metastases. Incomplete gross tumour resection with additional irradiation is an acceptable therapeutic option for adenoid cystic carcinoma. Interventional endoscopy with tumour debulking or tracheal stenting and/or definitive mediastinal radiotherapy are treatment alternatives in either a locally advanced or palliative setting.


Asunto(s)
Broncoscopía , Carcinoma Adenoide Quístico , Carcinoma de Células Escamosas , Estadificación de Neoplasias , Tráquea , Neoplasias de la Tráquea , Neoplasias de la Tráquea/cirugía , Neoplasias de la Tráquea/patología , Neoplasias de la Tráquea/diagnóstico , Neoplasias de la Tráquea/terapia , Neoplasias de la Tráquea/diagnóstico por imagen , Humanos , Carcinoma Adenoide Quístico/patología , Carcinoma Adenoide Quístico/cirugía , Carcinoma Adenoide Quístico/diagnóstico por imagen , Carcinoma Adenoide Quístico/terapia , Carcinoma Adenoide Quístico/diagnóstico , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/cirugía , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/terapia , Carcinoma de Células Escamosas/diagnóstico por imagen , Tráquea/cirugía , Tráquea/patología , Tráquea/diagnóstico por imagen , Pronóstico , Terapia Combinada , Tomografía Computarizada por Rayos X , Stents , Cuidados Paliativos
18.
Medicine (Baltimore) ; 103(6): e37033, 2024 Feb 09.
Artículo en Inglés | MEDLINE | ID: mdl-38335397

RESUMEN

INTRODUCTION: Primary tracheal acinic cell carcinoma (ACC) is an exceptionally rare malignancy, posing challenges in understanding its clinical behavior and optimal management. Surgical resection has traditionally been the primary treatment modality, but we present a compelling case of tracheal ACC managed with endotracheal intervention, challenging conventional approaches. PATIENT CONCERNS: A 53-year-old woman presented with shortness of breath, cough, and hemoptysis. Enhanced computed tomography revealed an obstructive tracheal lesion, leading to her referral for further assessment. DIAGNOSIS: Microscopic evaluation, immunohistochemistry, and clinical assessments confirmed primary tracheal ACC, an exceedingly rare condition with limited clinical insights. INTERVENTIONS: We utilized rigid bronchoscopy to perform endotracheal intervention, successfully resecting the tumor and restoring tracheal patency. Postoperatively, the patient received no radiotherapy or chemotherapy. OUTCOMES: The patient achieved complete recovery, with 24-month follow-up examinations indicating no recurrence or metastatic disease. Only minimal scar tissue remained at the resection site. CONCLUSION: This case demonstrates the potential of endotracheal intervention as a curative approach for primary tracheal ACC, minimizing invasiveness and preserving tracheal function. Collaborative research efforts and extensive case reporting are crucial for advancing our understanding of this rare malignancy and optimizing treatment strategies for improved patient outcomes.


Asunto(s)
Carcinoma de Células Acinares , Neoplasias de la Tráquea , Humanos , Femenino , Persona de Mediana Edad , Neoplasias de la Tráquea/cirugía , Neoplasias de la Tráquea/patología , Carcinoma de Células Acinares/cirugía , Carcinoma de Células Acinares/patología , Tráquea/cirugía , Tráquea/patología , Broncoscopía/métodos , Tomografía Computarizada por Rayos X
19.
Vet Radiol Ultrasound ; 65(3): 246-249, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38414109

RESUMEN

A 13-year-old spayed female Persian cat presented with dyspnea and nasal discharge. Thoracic radiography revealed a dome-shaped soft-tissue opacity in the carina. Computed tomography confirmed a soft tissue-attenuating mass in the carina and the left and right proximal main bronchi that appeared to arise from the tracheal wall. Tracheoscopy revealed an intraluminal broad-based mass with multilobulated borders at the same location. Histopathological evaluation revealed a benign neoplastic process of the glandular epithelial lineage, which was considered an adenoma. Tracheal adenomas should be included in the differential diagnosis of tracheal masses.


Asunto(s)
Adenoma , Enfermedades de los Gatos , Tomografía Computarizada por Rayos X , Neoplasias de la Tráquea , Animales , Gatos , Femenino , Enfermedades de los Gatos/diagnóstico por imagen , Enfermedades de los Gatos/patología , Neoplasias de la Tráquea/veterinaria , Neoplasias de la Tráquea/diagnóstico por imagen , Adenoma/veterinaria , Adenoma/diagnóstico por imagen , Adenoma/patología , Tomografía Computarizada por Rayos X/veterinaria , Diagnóstico Diferencial , Tráquea/diagnóstico por imagen , Tráquea/patología , Radiografía Torácica/veterinaria
20.
Einstein (Sao Paulo) ; 22: eRC0528, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38324847

RESUMEN

Schwannomas commonly develop in the cervical region, 25% - 45% of cases are diagnosed in this anatomical region. Tracheal neurogenic tumors are exceedingly rare and can be misdiagnosed as invasive thyroid carcinomas or other infiltrating malignancies when present at the level of the thyroid gland. Here, we present a case of synchronous benign cervical schwannoma with tracheal invasion and papillary thyroid carcinoma in a patient who was initially hospitalized for COVID-19. The patient presented with dyspnea that was later found to be caused by tracheal extension of a cervical tumor. Surgical excision was performed, and the surgical team proceeded with segmental tracheal resection, removal of the cervical mass, and total thyroidectomy. The specimen was sent for pathological analysis, which revealed synchronous findings of a benign cervical schwannoma with tracheal invasion and papillary thyroid carcinoma. The literature on this subject, together with the present case report, suggests that neurogenic tumors should be included in the differential diagnosis of obstructing tracheal cervical masses. Surgical excision is the first-line of treatment for benign cervical schwannomas.


Asunto(s)
Neurilemoma , Neoplasias de la Tiroides , Neoplasias de la Tráquea , Humanos , Cáncer Papilar Tiroideo , Tráquea/diagnóstico por imagen , Tráquea/cirugía , Neoplasias de la Tiroides/diagnóstico por imagen , Neoplasias de la Tiroides/cirugía , Neoplasias de la Tiroides/patología , Neoplasias de la Tráquea/diagnóstico por imagen , Neoplasias de la Tráquea/cirugía , Neoplasias de la Tráquea/patología , Neurilemoma/diagnóstico por imagen , Neurilemoma/cirugía , Neurilemoma/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...